News
Needleless Partners and Taipei Medical University Healthcare System AI-Driven Infusion Advancement Showcases Taiwan’s Independent R&D and Manufacturing Power
Needleless Partners and Taipei Medical University Healthcare System
AI-Driven Infusion Advancement Showcases Taiwan’s Independent R&D and Manufacturing Power
The Taipei Medical University (TMU) Healthcare System has fully implemented the “SmartMed Infusion System” developed by Ingrasys, becoming Taiwan’s first medical network to adopt a fully connected, prescription-linked smart infusion solution. The system integrates Needleless’s high-quality infusion sets to create an intelligent, closed-loop medication administration platform that enhances both patient safety and clinical efficiency.
The TMU healthcare network, comprising TMU Hospital, Wan Fang Hospital, Shuang Ho Hospital, and the New People’s Hospital, has deployed 1,080 smart infusion pumps. Fully integrated with its HIS 3.0 system, the solution automatically cross-verifies patient, prescription, and medication data while auto-configuring infusion parameters. Within the first three months of operation, the system successfully intercepted 136 potential near misses—achieving a 0.44% error prevention rate—demonstrating its outstanding capability in safeguarding patient safety.
As a core manufacturing partner in the SmartMed Infusion System, Needleless is responsible for the design and production of multiple smart-connected infusion sets under ISO 13485-compliant processes. The Chairman of Needleless stated, “The advancement of smart healthcare relies not only on AI and software, but equally on innovation in critical infusion hardware. Needleless has long been dedicated to advancing infusion technologies and smart manufacturing, and will continue to collaborate with Ingrasys and hospitals to accelerate the real-world application of intelligent medical solutions.”
Through this collaboration, Needleless demonstrates its robust manufacturing capacity and expertise in medical device integration, marking a milestone in Taiwan’s advancement toward independently developed smart healthcare technologies. Moving forward, Needleless will continue expanding its presence in intelligent infusion and digital health, leading the transformation of infusion consumables toward smarter, more connected, and safer solutions—serving as a cornerstone of the AI-driven healthcare era.
Source: https://www.ctee.com.tw/news/20241119700731-430502
